Cardiovascular
Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
- Acute Phase Reactants(17)
- Angina(14)
- Arrhythmia(85)
- Atherosclerosis(93)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(46)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(131)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(10)
- Endothelium(35)
- Erythrocytes & Hemoglobin(53)
- Heart Failure(32)
- Hypertension(167)
- Hypotension(24)
- Lipoproteins(66)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(64)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(37)
- Storage & Transport(6)
- Stroke(53)
- Vasoconstriction(61)
- Thrombosis(58)
- Vasodilation(146)
Cardiovascular 相关产品(860)
- GC43281Clopidogrel Carboxylic Acid (hydrochloride)CAS: 144750-42-5纯度: >95.00%
A major inactive metabolite of clopidogrel
- GC43328C-Type Natriuretic Peptide-22 (human, porcine, rat) (trifluoroacetate salt)纯度: >95.00%
A peptide with diverse biological activities
- GC43333CV-6209 (chloride)CAS: 100488-87-7纯度: >98.00%
CV-6209 (chloride)是一种强效的血小板活化因子受体拮抗剂，对兔血小板的IC 50 值为75nM。
- GC43371Dabigatran Acyl-β-D-GlucuronideCAS: 1015167-40-4纯度: >90.00%
A major active metabolite of dabigatran
- GC43399Dehydro Amlodipine (fumarate)CAS: 2138811-33-1纯度: >98.00%
A potential impurity found in commercial preparations of amlodipine
- GC43492DL-Propargyl Glycine (hydrochloride)CAS: 16900-57-5纯度: >97.00%
An irreversible inhibitor of H 2 S synthesis
- GC43646Ezetimibe Hydroxy GlucuronideCAS: 536709-33-8纯度: >95.00%
A minor phase II metabolite of ezetimibe
- GC43727Ganglioside GD1a mixture (sodium salt)CAS: 12707-58-3纯度: >98.00%
A mixture of ganglioside G D1a
- GC43745Geranyl Pyrophosphate (triammonium salt)CAS: 116057-55-7纯度: >90.00% / >98.00% / >95.00%
An intermediate in the mevalonate pathway
- GC43802HA-1004 (hydrochloride)CAS: 92564-08-4纯度: >98.00%
HA-1004 is an inhibitor of protein kinase G (PKG) and PKA (Kis = 1.4 and 2.3 μM, respectively).
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC43263 | Cholesteryl Stearate | 35602-69-8 | >97.00% | |
A cholesterol ester | ||||
| GC43270 | Ciprostene (calcium salt) | 81703-55-1 | >98.00% | |
A stable analog of PGI 2 | ||||
| GC43281 | Clopidogrel Carboxylic Acid (hydrochloride) | 144750-42-5 | >95.00% | |
A major inactive metabolite of clopidogrel | ||||
| GC43328 | C-Type Natriuretic Peptide-22 (human, porcine, rat) (trifluoroacetate salt) | - | >95.00% | |
A peptide with diverse biological activities | ||||
| GC43333 | CV-6209 (chloride) | 100488-87-7 | >98.00% | |
CV-6209 (chloride)是一种强效的血小板活化因子受体拮抗剂，对兔血小板的IC 50 值为75nM。 | ||||
| GC43371 | Dabigatran Acyl-β-D-Glucuronide | 1015167-40-4 | >90.00% | |
A major active metabolite of dabigatran | ||||
| GC43399 | Dehydro Amlodipine (fumarate) | 2138811-33-1 | >98.00% | |
A potential impurity found in commercial preparations of amlodipine | ||||
| GC43437 | Diallyl Disulfide | 2179-57-9 | >95.50% | |
A natural H 2 S donor | ||||
| GC43492 | DL-Propargyl Glycine (hydrochloride) | 16900-57-5 | >97.00% | |
An irreversible inhibitor of H 2 S synthesis | ||||
| GC43565 | Doxorubicinol (hydrochloride) | 63950-05-0 | >90.00% | |
A doxorubicin metabolite | ||||
| GC43569 | DPPP | 110231-30-6 | >95.00% | |
A fluorescent probe for detection of hydroperoxides | ||||
| GC43606 | Endothelin-1 (human, porcine) (trifluoroacetate salt) | - | >95.00% | |
A peptide vasoconstrictor | ||||
| GC43607 | Endothelin-2 (human) (trifluoroacetate salt) | - | >95.00% | |
A peptide vasoconstrictor | ||||
| GC43608 | Endothelin-3 (human, rat) (trifluoroacetate salt) | - | >95.00% | |
A peptide vasoconstrictor | ||||
| GC43646 | Ezetimibe Hydroxy Glucuronide | 536709-33-8 | >95.00% | |
A minor phase II metabolite of ezetimibe | ||||
| GC43727 | Ganglioside GD1a mixture (sodium salt) | 12707-58-3 | >98.00% | |
A mixture of ganglioside G D1a | ||||
| GC43732 | Ganglioside GM3 Mixture (sodium salt) | 54827-14-4 | >98.00% | |
A mixture of ganglioside G M3 | ||||
| GC43745 | Geranyl Pyrophosphate (triammonium salt) | 116057-55-7 | >90.00% / >98.00% / >95.00% | |
An intermediate in the mevalonate pathway | ||||
| GC43800 | GW 9578 | 247923-29-1 | >98.00% | |
A potent, selective PPARα agonist | ||||
| GC43802 | HA-1004 (hydrochloride) | 92564-08-4 | >98.00% | |
HA-1004 is an inhibitor of protein kinase G (PKG) and PKA (Kis = 1.4 and 2.3 μM, respectively). | ||||
| GC43803 | HA-1077 (hydrochloride) | 203911-27-7 | >98.00% | |
A ROCK inhibitor | ||||
| GC43869 | Homovanillic Acid sulfate (sodium salt) | - | >98.00% | |
A phenol and dopamine metabolite | ||||
| GC43883 | Hymeglusin | 29066-42-0 | >95.00% | |
An HMG-CoA synthase inhibitor | ||||
| GC43890 | ICI 216140 | 124001-41-8 | >95.00% | |
A GRP/bombesin receptor 2 antagonist | ||||